• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
ProAxsis CEO attending DxPx conference
Share
DxPx Conference
News

ProAxsis CEO attending DxPx conference

November 4, 2021
-
Posted by Jessica Robinson

Our CEO, Dr David Ribeiro, will be attending the DxPx Conference, taking place face-to-face in Dusseldorf and in a virtual format, November 12th – 20th 2021.

ProAxsis are actively seeking commercial partners for our portfolio of respiratory diagnostics in key territories.  These include:

  • Laboratory-based assays for active protease biomarkers associated with chronic respiratory diseases such as cystic fibrosis, bronchiectasis and COPD.
  • NEATstik, a qualitative point-of-care test for active neutrophil elastase.
  • Our Covid-19 serology test, developed in partnership with AstraZeneca.

If your company has access to pre-existing networks of key respiratory groups, and you’d be interested in exploring any of these exciting opportunities then please contact David to request a meeting via info@proaxsis.com or the DxPx conference partnering system.

November 4, 2021

Related News

Other posts that you should not miss.
News

Belfast Telegraph Awards

May 17, 2022
-
Posted by Jessica Robinson

Presenting the high-achieving NI companies hoping for Belfast Telegraph Business Awards 2022 success – BelfastTelegraph.co.uk The team …

Read More
May 17, 2022
Posted by Jessica Robinson
News

New opportunity for Early Stage Researcher at Queen’s University Belfast

March 6, 2018
-
Posted by David Ribeiro

ProAxsis is proud to be collaborating with Dr. Gunnar Schroeder and Prof. Cliff Taggart from the School …

Read More
March 6, 2018
Posted by David Ribeiro
News, ProteaseTag®

ProAxsis receives Royal visit

October 19, 2016
-
Posted by Webmaster

ProAxsis were this week delighted to host His Royal Highness, the Duke of York, at their new laboratory …

Read More
October 19, 2016
Posted by Webmaster
← PREVIOUS POST
ProAxsis releases new NEATstik® data at the Irish Thoracic Society Conference 2021
NEXT POST →
ProAxsis makes significant progress towards measuring bone health with a new innovation for patients at high risk of osteoporotic fractures
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
    June 7, 2021

    ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it …

  • ProAxsis Ltd CEO Update Report – May 2021
    May 21, 2021

    Introduction In parallel with the release of the company’s 2020 financial statements, I …

  • ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
    February 21, 2021

    ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • July 26, 2022
    ProAxsis announces additional key appointments
  • May 17, 2022
    Belfast Telegraph Awards
  • May 16, 2022
    ProAxsis announces “impressive” results in Performance Evaluation of COVID-19 antibody test
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis CEO attending DxPx conference - ProAxsis